Ausgabe 4/2016
Inhalt (17 Artikel)
Short overview on the current treatment of chronic myeloid leukemia in chronic phase
Stefan Schmidt
DA-EPOCH-R: An alternative treatment for high-risk diffuse large B cell lymphoma?
Michael Panny, Thomas Nösslinger
Primary non-Hodgkin’s lymphoma of the gingiva: a case report and review of the literature
Ilson Sepúlveda, Max Schorwer, Enrique Platin, Milly Yañez, Felipe Fredes
Therapy for EGFR tyrosine kinase inhibitor-resistant NSCLC with a focus on the T790M-resistant mutation
August Zabernigg
Recommendations of the Austrian Working Group on Pulmonary Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
Helmut H. Popper, Ulrike Gruber-Mösenbacher, Georg Hutarew, Maximilian Hochmair, Gudrun Absenger, Luka Brcic, Leonhard Müllauer, Gerhard Dekan, Ulrike Setinek, Dagmar Krenbek, Michael Vesely, Robert Pirker, Wolfgang Hilbe, Rainer Kolb, Gerald Webersinke, Tamara Hernler, Georg Pall, Sigurd Lax, Andrea Mohn-Staudner
PD-L1 testing, fit for routine evaluation? From a pathologist’s point of view
Georg Hutarew
Soft tissue sarcomas & GIST
Sophie Roider-Schur, Rainer Hamacher, Thomas Brodowicz
Extravasation emergencies: state-of-the-art management and progress in clinical research
Ursula Pluschnig, Werner Haslik, Rupert Bartsch, Robert M. Mader